NociPharm Inc. is committed to create, develop and market innovative and technologically advanced products rooted in front-line biomedical science; making excellence, quality, integrity and innovation the hallmarks of a business that meets the needs of patients, physicians, the healthcare system and related customers.
NociPharm’s vision is to focus on research, development and product application of a technology platform that targets the nociceptor system. Its products target improved wound healing, analgesics and inflammation. Relying on its proprietary H+ core technology as a rigorously pursued starting base, the company positions its products as third generation analgesics and inflammation, as well as wellness-related cosmeceuticals, following broadly based initiatives including strategic alliances for specialty manufacturing and distribution.
